Evidence map›Paper›PMID 38791348›Full record

ArticleInternational journal of molecular sciences2024

Gelatin-Coated TiO

Periasamy Anbu, Muruganantham Rethinasabapathy, Anbazhagan Sathiyaseelan, Xin Zhang, Myeong-Hyeon Wang, Sekar Vijayakumar, Yun Suk Huh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Periasamy AnbuDepartment of Biological Engineering, Inha University, Incheon 22212, Republic of Korea.
Muruganantham RethinasabapathyNanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Incheon 22212, Republic of Korea.
Anbazhagan SathiyaseelanDepartment of Medical Biotechnology, College of Biomedical Sciences, Kangwon National University, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0001-8142-0063
Xin ZhangDepartment of Medical Biotechnology, College of Biomedical Sciences, Kangwon National University, Chuncheon-si 24341, Republic of Korea.
Myeong-Hyeon WangDepartment of Medical Biotechnology, College of Biomedical Sciences, Kangwon National University, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0003-1760-1622
Sekar VijayakumarMarine College, Shandong University, Weihai 264209, China.ORCID 0000-0001-8211-069X
Yun Suk HuhNanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Incheon 22212, Republic of Korea.ORCID 0000-0003-1612-4473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hybrid nanomaterials have attracted considerable interest in biomedicine because of their fascinating characteristics and wide range of applications in targeted drug delivery, antibacterial activity, and cancer treatment. This study developed a gelatin-coated Titanium oxide/palladium (TiO

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsEscherichia coliGelatinNanostructuresPalladiumTitaniumA549 CellsBacillus subtilisHumansMetal NanoparticlesMicrobial Sensitivity TestsX-Ray DiffractionAnti-Bacterial AgentsAntineoplastic AgentsGelatinPalladiumTitaniumtitanium dioxideantibacterial activityanticancer activitygelatinpalladium nanoparticlestitanium oxide nanoparticles

Identifiers

PMID38791348
PMCPMC11121089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.